King Taj D, Gandy Johanna C, Bijur Gautam N
Department of Psychiatry and Behavioral Neurobiology, Sparks Center 1009, University of Alabama at Birmingham, Birmingham, AL 35294-0017, USA.
Exp Cell Res. 2006 Nov 1;312(18):3693-700. doi: 10.1016/j.yexcr.2006.08.010. Epub 2006 Aug 17.
The ubiquitously expressed protein glycogen synthase kinase-3 (GSK3) is constitutively active, however its activity is markedly diminished following phosphorylation of Ser21 of GSK3alpha and Ser9 of GSK3beta. Although several kinases are known to phosphorylate Ser21/9 of GSK3, for example Akt, relatively much less is known about the mechanisms that cause the dephosphorylation of GSK3 at Ser21/9. In the present study KCl-induced plasma membrane depolarization of SH-SY5Y cells, which increases intracellular calcium concentrations caused a transient decrease in the phosphorylation of Akt at Thr308 and Ser473, and GSK3 at Ser21/9. Overexpression of the selective protein phosphatase-1 inhibitor protein, inhibitor-2, increased basal GSK3 phosphorylation at Ser21/9 and significantly blocked the KCl-induced dephosphorylation of GSK3beta, but not GSK3alpha. The phosphorylation of Akt was not affected by the overexpression of inhibitor-2. GSK3 activity is known to affect sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) levels. Overexpression of inhibitor-2 or treatment of cells with the GSK3 inhibitors lithium and SB216763 increased the levels of SERCA2. These results indicate that the protein phosphatase-1/inhibitor-2 complex differentially regulates GSK3 dephosphorylation induced by KCl and that GSK3 activity regulates SERCA2 levels.
普遍表达的蛋白糖原合酶激酶-3(GSK3)具有组成性活性,然而,在GSK3α的Ser21和GSK3β的Ser9磷酸化后,其活性会显著降低。尽管已知几种激酶可使GSK3的Ser21/9磷酸化,例如Akt,但对于导致GSK3在Ser21/9去磷酸化的机制了解相对较少。在本研究中,KCl诱导的SH-SY5Y细胞膜去极化增加了细胞内钙浓度,导致Thr308和Ser473位点的Akt以及Ser21/9位点的GSK3磷酸化出现短暂下降。选择性蛋白磷酸酶-1抑制蛋白抑制剂-2的过表达增加了Ser21/9位点的基础GSK3磷酸化,并显著阻断了KCl诱导的GSK3β去磷酸化,但对GSK3α没有影响。抑制剂-2的过表达对Akt的磷酸化没有影响。已知GSK3活性会影响肌浆网/内质网钙ATP酶2(SERCA2)的水平。抑制剂-2的过表达或用GSK3抑制剂锂和SB216763处理细胞会增加SERCA2的水平。这些结果表明,蛋白磷酸酶-1/抑制剂-2复合物对KCl诱导的GSK3去磷酸化具有差异性调节作用,并且GSK3活性调节SERCA2水平。